With Trump's backing, the pharma industry is leaning into the idea of more "direct-to-consumer" sales. But experts say the ...

President Trump may aggressively negotiate lower drug prices in Medicare using a program that Democrats created and Trump ...

Kelvin Droegemeier, a Trump adviser in his first term, is leading an effort to offer an alternative to the administration’s ...

The lack of findings thus far in the Baby’s First Years study should not be used to justify actions that will further hurt ...

In January, one of the deadliest wildfires in U.S. history ravaged several neighborhoods in Los Angeles County, including ...

The Texas measles outbreak that sickened 762 people since late January is over, state health officials said Monday.

Hello, hello — glad you’re here! Some housekeeping: Health Care Inc. is off until Sept. 8. I’m also going on parental leave ...

Robert F. Kennedy Jr. has said the CDC's vaccine advisory board was rife with conflicts of interest. A new analysis shows ...

An experimental Pfizer sickle cell treatment failed to meet the main goal in a late-stage trial for patients aged 16 and ...

Theresa Gaffney is the lead Morning Rounds writer and reports on health care, new research, and public policy, with a ...

Morning. Today, we examine the plush pay packages of health care’s top CEOs in 2024. Also, we discuss Stealth BioTherapeutics’ efforts to rally support behind its Barth syndrome drug, and hear more ...

In a highly unusual move, a small biotech has disclosed a rejection letter from the FDA in hopes of rallying support for ...